Share your certification

AbbVie

95%

Employees say this is a great place to work

Company Overview

About AbbVie

AbbVie is a global biopharmaceutical company committed to developing innovative therapies for some of the world’s most complex conditions. In Australia we employ more than 450 people with our therapies currently benefiting more than 30,000 Australians across several therapeutic areas: Immunology, Oncology, Virology, Neuroscience and Aesthetics.

COMPANY SIZE

337 Employees

(Medium)

INDUSTRY

Health Care

Company culture at AbbVie

The employee experience at AbbVie, compared to a typical Australia-based company
95% of employees at AbbVie say it is a great place to work compared to 55% of employees at a typical Australia-based company
AbbVie 95%
Typical company 55%

Source: Great Place to Work® 2019 Australia National Employee Engagement Study

0 %
People here are treated fairly regardless of their gender
0 %
Management is honest and ethical in its business practices
0 %
When you join the company, you are made to feel welcome
0 %
I am able to take time off from work when I think it's necessary
0 %
When I look at what we accomplish, I feel a sense of pride

Life at AbbVie

Previous
Next

Don't see your company listed?

Nominate your company to be Great Place to Work Certified™

I want to get recognized!

ABOUT OUR METHOLOGY​

To be eligible for the World’s Best Workplaces list, a company must apply and be named to a minimum of 5 national Best Workplaces lists within our current 58 countries, have 5,000 employees or more worldwide, and at least 40% of the company’s workforce (or 5,000 employees) must be based outside of the home country. Extra points are given based on the number of countries where a company surveys employees with the Great Place to Work Trust Index©, and the percentage of a company’s workforce represented by all Great Place to Work surveys globally. Candidates for the 2017 Worlds Best Workplaces list will have appeared on national workplaces lists published in September 2016 through August 2017.

ABOUT OUR METHOLOGY​